Acinetobacter baumannii in the critically ill: complex infections get complicated
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acinetobacter baumannii in the critically ill: complex infections get complicated
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-06-23
DOI
10.3389/fmicb.2023.1196774
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome
- (2023) Alessandra Iacovelli et al. BMC Pulmonary Medicine
- Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection
- (2023) Afreen Shadan et al. Frontiers in Cellular and Infection Microbiology
- Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy
- (2023) Davide Mangioni et al. Microbiology Spectrum
- Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
- (2023) Katarina Novović et al. Antibiotics-Basel
- High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii
- (2022) Massimiliano De Angelis et al. Antibiotics-Basel
- Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
- (2022) Carmi Bartal et al. Infectious Diseases and Therapy
- Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
- (2022) P. V. Geetha et al. Journal of Laboratory Physicians
- Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
- (2022) Marco Falcone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam
- (2022) Viviane Chaiben et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens
- (2022) Selene Rebecca Boncompagni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
- (2022) Alina Iovleva et al. mBio
- Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
- (2022) Chuanhai Wang et al. Frontiers in Pharmacology
- Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection
- (2022) Subhasree Roy et al. Frontiers in Medicine
- Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)
- (2022) Giusy Tiseo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies
- (2022) Soffi Kei Kei Law et al. MICROBIOLOGICAL RESEARCH
- Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared
- (2022) Francesco Cogliati Dezza et al. Antibiotics-Basel
- Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
- (2022) Marisol Wences et al. Antibiotics-Basel
- Acinetobacter baumannii pneumonia increases surfactant proteins SP-A, SP-B, and SP-D levels, while decreasing SP-C level in bronchoalveolar lavage in rats
- (2022) Talat Oğulcan Özarslan et al. MICROBES AND INFECTION
- Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
- (2022) Tsung-Ta Chiang et al. Frontiers in Cellular and Infection Microbiology
- Molecular mechanisms of antibiotic resistance revisited
- (2022) Elizabeth M. Darby et al. NATURE REVIEWS MICROBIOLOGY
- Outer membrane vesicles containing OmpA induce mitochondrial fragmentation to promote pathogenesis of Acinetobacter baumannii
- (2021) Varnesh Tiku et al. Scientific Reports
- Overexpression of Efflux Pumps, Mutations in the Pumps’ Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study
- (2021) Subhasree Roy et al. Frontiers in Microbiology
- Epidemiology of Biofilm Producing Acinetobacter baumannii Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study
- (2021) Ahmed Morad Asaad et al. Infection and Drug Resistance
- Effect of N-Acetylcysteine Administration on 30-Day Mortality in Critically Ill Patients with Septic Shock Caused by Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii: A Retrospective Case-Control Study
- (2021) Alessandra Oliva et al. Antibiotics-Basel
- Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient
- (2021) Wasan Katip et al. Antibiotics-Basel
- Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii
- (2021) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
- (2021) Jacinda C. Abdul-Mutakabbir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
- (2021) Alessandro Russo et al. INFECTION
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals
- (2021) Susan Ibrahim et al. MOLECULAR BIOLOGY REPORTS
- Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
- (2021) Yoshinori Sato et al. Scientific Reports
- Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review
- (2021) Alemu Gedefie et al. Infection and Drug Resistance
- Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It
- (2021) Chaoying Ma et al. Vaccines
- The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection
- (2021) Enea Gino Di Domenico et al. Microbiology Spectrum
- Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan
- (2021) Noor Andryan Ilsan et al. Microorganisms
- Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
- (2021) Davide Fiore Bavaro et al. Antibiotics-Basel
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
- (2021) Mical Paul et al. CLINICAL MICROBIOLOGY AND INFECTION
- Acinetobacter baumannii: Virulence Strategies and Host Defense Mechanisms
- (2021) Varnesh Tiku DNA AND CELL BIOLOGY
- Acinetobacter baumannii
- (2021) Clémence Whiteway et al. TRENDS IN MICROBIOLOGY
- A LysR-Type Transcriptional Regulator Controls Multiple Phenotypes in Acinetobacter baumannii
- (2021) Aimee R. P. Tierney et al. Frontiers in Cellular and Infection Microbiology
- A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol
- (2021) Milo Gatti et al. Journal of Global Antimicrobial Resistance
- Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
- (2021) Wasan Katip et al. Pharmaceutics
- Cefiderocol for Severe Carbapenem-Resistant A. baumannii Pneumonia: Towards the Comprehension of Its Place in Therapy
- (2021) Emanuele Rando et al. Antibiotics-Basel
- Place in Therapy of the Newly Available Armamentarium for Multi-Drug-Resistant Gram-Negative Pathogens: Proposal of a Prescription Algorithm
- (2021) Lorenzo Volpicelli et al. Antibiotics-Basel
- Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
- (2020) Alejandro Iregui et al. Microbial Drug Resistance
- Distribution of carbapenem resistant Acinetobacter baumannii with blaADC-30 and induction of ADC-30 in response to beta-lactam antibiotics
- (2020) Birson Ingti et al. RESEARCH IN MICROBIOLOGY
- Glycomics Microarrays Reveal Differential In Situ Presentation of the Biofilm Polysaccharide Poly-N-acetylglucosamine on Acinetobacter baumannii and Staphylococcus aureus Cell Surfaces
- (2020) Andrea Flannery et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece
- (2020) Mattia Palmieri et al. Frontiers in Microbiology
- New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
- (2020) Bingbing Sun et al. mSphere
- Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
- (2020) Georgios Papathanakos et al. Microorganisms
- Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment
- (2020) Soroosh Monem et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biofilm dispersion
- (2020) Kendra P. Rumbaugh et al. NATURE REVIEWS MICROBIOLOGY
- High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital
- (2020) Patricia Cornejo-Juárez et al. PLoS One
- The Characterization of Two-Component System PmrA/PmrB in Cronobacter sakazakii
- (2020) Jingjing Hua et al. Frontiers in Microbiology
- The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017
- (2020) Olaniyi Ayobami et al. Antimicrobial Resistance and Infection Control
- Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3
- (2020) Saquib Malik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AbaR is a LuxR type regulator essential for motility and the formation of biofilm and pellicle in Acinetobacter baumannii
- (2020) Man Hwan Oh et al. Genes & Genomics
- Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients
- (2020) S. Karakonstantis et al. JOURNAL OF HOSPITAL INFECTION
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii
- (2020) Qin Peng et al. Scientific Reports
- The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen
- (2020) Siva R. Uppalapati et al. Frontiers in Microbiology
- Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively- and pan-resistant Acinetobacter baumannii
- (2020) A. Oliva et al. Journal of Global Antimicrobial Resistance
- Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)
- (2020) Naoki Kohira et al. Journal of Global Antimicrobial Resistance
- A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
- (2020) Wasan Katip et al. Antibiotics-Basel
- Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens
- (2020) Christine A. Pybus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
- (2020) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biofilm Production by Carbapenem-Resistant Klebsiella pneumoniae Significantly Increases the Risk of Death in Oncological Patients
- (2020) Enea Gino Di Domenico et al. Frontiers in Cellular and Infection Microbiology
- Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy
- (2019) Viviana Cafiso et al. Frontiers in Microbiology
- Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment
- (2019) Evangelia-Theophano Piperaki et al. CLINICAL MICROBIOLOGY AND INFECTION
- Identification of a novel plasmid carries mcr-4.3 in Acinetobacter baumannii from China
- (2019) Furong Ma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation
- (2019) Sutep Jaruratanasirikul et al. CLINICAL DRUG INVESTIGATION
- Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
- (2019) Cheng-Hong Yang et al. MOLECULES
- Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients
- (2019) Habib Zeighami et al. BMC INFECTIOUS DISEASES
- The structure of Acinetobacter secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone–substrate interaction
- (2019) Darya V. Urusova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
- (2019) Vincent Trebosc et al. mBio
- The Mechanisms of Disease Caused by Acinetobacter baumannii
- (2019) Faye C. Morris et al. Frontiers in Microbiology
- Use of colistin in adult patients: a cross-sectional study
- (2019) Daniele Roberto Giacobbe et al. Journal of Global Antimicrobial Resistance
- The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system
- (2019) Renatas Krasauskas et al. BMC MICROBIOLOGY
- Rapid microevolution of biofilm cells in response to antibiotics
- (2019) Anahit Penesyan et al. npj Biofilms and Microbiomes
- Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
- (2019) Mohammad Hamidian et al. Microbial Genomics
- Prevalence of Genes Involved in Colistin Resistance in Acinetobacter baumannii: First Report from Iraq
- (2019) Israa M.S. Al-Kadmy et al. Microbial Drug Resistance
- Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS
- (2018) Deanna Deveson Lucas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of Novel Acinetobacter baumannii Type VI Secretion System Anti-Bacterial Effector and Immunity Pairs
- (2018) Timothy C. Fitzsimons et al. INFECTION AND IMMUNITY
- In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms
- (2018) Simona Pollini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Proposal for assignment of allele numbers for mobile colistin resistance (mcr) genes
- (2018) Sally R Partridge et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increasing rates of Acinetobacter baumannii infection and resistance in an oncology department
- (2018) Shiwen Zhou et al. Journal of Cancer Research and Therapeutics
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
- (2018) Yoshinori Sato et al. PLoS One
- Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia
- (2018) Yung-Chih Wang et al. Scientific Reports
- Acinetobacter: an emerging pathogen with a versatile secretome
- (2018) Noha M. Elhosseiny et al. Emerging Microbes & Infections
- Acinetobacter baumannii maintains its virulence after long-time starvation
- (2018) Itziar Chapartegui-González et al. PLoS One
- Antimicrobial susceptibility testing for polymyxins: challenges, issues, and recommendations
- (2018) Fereshteh Ezadi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII
- (2018) Ursula Waack et al. mBio
- Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments
- (2018) Emmanuel Eze et al. Infection and Drug Resistance
- Resistance to polymyxins in Gram-negative organisms
- (2017) Katy Jeannot et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
- (2017) J Nowak et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PathogenicAcinetobacterspecies have a functional type I secretion system and contact-dependent inhibition systems
- (2017) Christian M. Harding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overproduction of outer membrane protein A (OmpA) by Acinetobacter baumannii is a risk factor for nosocomial pneumonia, bacteremia and mortality increase.
- (2017) Viviana Sánchez-Encinales et al. JOURNAL OF INFECTIOUS DISEASES
- Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates
- (2017) Ali Mohammadi Bardbari et al. MICROBIAL PATHOGENESIS
- Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin
- (2017) Matthew Joseph Powers et al. MOLECULAR MICROBIOLOGY
- Uncovering the mechanisms of Acinetobacter baumannii virulence
- (2017) Christian M. Harding et al. NATURE REVIEWS MICROBIOLOGY
- The Secrets of Acinetobacter Secretion
- (2017) Brent S. Weber et al. TRENDS IN MICROBIOLOGY
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2017) Anna Giammanco et al. mSphere
- The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii
- (2016) Christine Greene et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture
- (2016) Yung-Chih Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria
- (2016) Giovanna Batoni et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
- (2016) Sibylle H. Lob et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups ofAcinetobacter baumanniiin Iran
- (2016) Alka Hasani et al. Microbial Drug Resistance
- Bacterial Sphingomyelinases and Phospholipases as Virulence Factors
- (2016) Marietta Flores-Díaz et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Aim, Load, Fire: The Type VI Secretion System, a Bacterial Nanoweapon
- (2016) Francesca R. Cianfanelli et al. TRENDS IN MICROBIOLOGY
- The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner
- (2016) Grace E. Richmond et al. mBio
- Biofilm may not be Necessary for the Epidemic Spread of Acinetobacter baumannii
- (2016) Yuan Hu et al. Scientific Reports
- Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
- (2016) Meredith S. Wright et al. Genome Medicine
- Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence
- (2016) Christian M. Harding et al. PLoS Pathogens
- Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives
- (2016) Mohamed Rhouma et al. Frontiers in Microbiology
- Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump
- (2015) Xinlong He et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Environmental factors that shape biofilm formation
- (2015) Masanori Toyofuku et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Clinical infectious outcomes associated with biofilm-related bacterial infections: a retrospective chart review
- (2015) Alice E. Barsoumian et al. BMC INFECTIOUS DISEASES
- The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit
- (2015) Giancarlo Ceccarelli et al. BMC INFECTIOUS DISEASES
- Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones
- (2015) Li-mei Luo et al. BMC MICROBIOLOGY
- A review on colistin nephrotoxicity
- (2015) Atefeh Ordooei Javan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Optimum treatment strategies for carbapenem-resistantAcinetobacter baumanniibacteremia
- (2015) José Garnacho-Montero et al. Expert Review of Anti-Infective Therapy
- Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075
- (2015) Kyle A. Tipton et al. JOURNAL OF BACTERIOLOGY
- Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization andIn VivoFitness
- (2015) Tanya L. Johnson et al. JOURNAL OF BACTERIOLOGY
- Characteristics and Outcomes ofAcinetobacter baumanniiInfections in Critically Ill Patients with Cancer: A Matched Case–Control Study
- (2015) Lama H. Nazer et al. Microbial Drug Resistance
- Contribution of Resistance-Nodulation-Cell Division Efflux Systems to Antibiotic Resistance and Biofilm Formation in Acinetobacter baumannii
- (2015) Eun-Jeong Yoon et al. mBio
- Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
- (2015) Shu-Chen Kuo et al. Frontiers in Microbiology
- Crystallization and preliminary X-ray diffraction analysis of the Csu pili CsuC–CsuA/B chaperone–major subunit pre-assembly complex fromAcinetobacter baumannii
- (2015) Natalia Pakharukova et al. Acta Crystallographica Section F-Structural Biology Communications
- Differential Role of the T6SS in Acinetobacter baumannii Virulence
- (2015) Guillermo D. Repizo et al. PLoS One
- Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D
- (2015) Julia Stahl et al. PLoS One
- Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii
- (2014) Bart A Eijkelkamp et al. BMC GENOMICS
- Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
- (2014) Hao-Yuan Lee et al. CRITICAL CARE MEDICINE
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blocking Phosphatidylcholine Utilization in Pseudomonas aeruginosa, via Mutagenesis of Fatty Acid, Glycerol and Choline Degradation Pathways, Confirms the Importance of This Nutrient Source In Vivo
- (2014) Zhenxin Sun et al. PLoS One
- Characterisation of Pellicles Formed by Acinetobacter baumannii at the Air-Liquid Interface
- (2014) Yassine Nait Chabane et al. PLoS One
- Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients
- (2014) Aziz Ogutlu et al. Annals of Clinical Microbiology and Antimicrobials
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China
- (2014) Lu Nie et al. Acta Pharmaceutica Sinica B
- The Biology of the PmrA/PmrB Two-Component System: The Major Regulator of Lipopolysaccharide Modifications
- (2013) H. Deborah Chen et al. Annual Review of Microbiology
- Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii
- (2013) Younes Smani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of a Novel Murine Wound Model of Acinetobacter baumannii Infection
- (2013) Mitchell G. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces
- (2013) S. J. Orsinger-Jacobsen et al. MICROBIOLOGY-SGM
- Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
- (2012) L. Fernandez et al. CLINICAL MICROBIOLOGY REVIEWS
- The Rise of Carbapenem-Resistant Acinetobacter baumannii
- (2012) Benjamin A. Evans et al. CURRENT PHARMACEUTICAL DESIGN
- Probing the molecular determinant of the lipase-specific foldase Lif26 for the interaction with its cognate Lip26
- (2012) Xiaomei Zheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains
- (2012) B. Ozbek et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii
- (2012) E. Sugawara et al. JOURNAL OF BACTERIOLOGY
- Acinetobacter baumannii outer membrane protein a modulates the biogenesis of outer membrane vesicles
- (2012) Dong Chan Moon et al. JOURNAL OF MICROBIOLOGY
- NaxD is a deacetylase required for lipid A modification andFrancisellapathogenesis
- (2012) Anna C. Llewellyn et al. MOLECULAR MICROBIOLOGY
- Comparison of the Virulence Potential of Acinetobacter Strains from Clinical and Environmental Sources
- (2012) Azam F. Tayabali et al. PLoS One
- Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells
- (2012) Younes Smani et al. PLoS One
- Detection of Quorum Sensing Signal Molecules and Identification of an Autoinducer Synthase Gene among Biofilm Forming Clinical Isolates of Acinetobacter spp.
- (2012) Deepa Anbazhagan et al. PLoS One
- Characterization of eDNA from the Clinical StrainAcinetobacter baumanniiAIIMS 7 and Its Role in Biofilm Formation
- (2012) Praveen K. Sahu et al. TheScientificWorldJOURNAL
- The OmpA family of proteins: Roles in bacterial pathogenesis and immunity
- (2012) Anthony W. Confer et al. VETERINARY MICROBIOLOGY
- The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
- (2012) Ignasi Roca et al. Frontiers in Microbiology
- Overexpression, purification, crystallization and preliminary X-ray crystallographic analysis of the periplasmic domain of outer membrane protein A fromAcinetobacter baumannii
- (2011) Jeong Soon Park et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime
- (2011) Guo-Bao Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane
- (2011) Jeong Soon Park et al. FASEB JOURNAL
- Biofilm formation byAcinetobacter baumanniistrains isolated from urinary tract infection and urinary catheters
- (2011) Nadia Kazemi Pour et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Adherence and motility characteristics of clinical Acinetobacter baumannii isolates
- (2011) Bart A. Eijkelkamp et al. FEMS MICROBIOLOGY LETTERS
- The Acinetobacter baumannii Biofilm-Associated Protein Plays a Role in Adherence to Human Epithelial Cells
- (2011) Kari A. Brossard et al. INFECTION AND IMMUNITY
- Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan
- (2011) Kai-Chih Chang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles
- (2011) Jong Sook Jin et al. PLoS One
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
- (2010) Adam Kulp et al. Annual Review of Microbiology
- Extended-Spectrum Cephalosporinase in Acinetobacter baumannii
- (2010) J.-M. Rodriguez-Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- Exopolymeric substances (EPS) from Bacillus subtilis : polymers and genes encoding their synthesis
- (2010) Massimiliano Marvasi et al. FEMS MICROBIOLOGY LETTERS
- Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
- (2010) A. C. Jacobs et al. INFECTION AND IMMUNITY
- Proteomic analysis of Acinetobacter baumannii in biofilm and planktonic growth mode
- (2010) Ji-Hyun Shin et al. JOURNAL OF MICROBIOLOGY
- Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
- (2010) T. N. Ellis et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum resistance ofAcinetobacter baumanniithrough the binding of factor H to outer membrane proteins
- (2009) Sang Woo Kim et al. FEMS MICROBIOLOGY LETTERS
- Regulation ofAcinetobacter baumanniibiofilm formation
- (2009) Jennifer A Gaddy et al. Future Microbiology
- The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells
- (2009) J. A. Gaddy et al. INFECTION AND IMMUNITY
- The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation
- (2009) A. H. K. Choi et al. JOURNAL OF BACTERIOLOGY
- Lipids in host–pathogen interactions: Pathogens exploit the complexity of the host cell lipidome
- (2009) Ynske P.M. van der Meer-Janssen et al. PROGRESS IN LIPID RESEARCH
- Diversity of Extended-Spectrum -Lactamases and Class C -Lactamases among Cloacal Escherichia coli Isolates in Belgian Broiler Farms
- (2008) A. Smet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biofilm formation in Acinetobacter baumannii: associated features and clinical implications
- (2008) J. Rodríguez-Baño et al. CLINICAL MICROBIOLOGY AND INFECTION
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Isolation and Characterization of an Autoinducer Synthase from Acinetobacter baumannii
- (2008) C. Niu et al. JOURNAL OF BACTERIOLOGY
- Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology
- (2008) A. P. Tomaras et al. MICROBIOLOGY-SGM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started